Skip to main content

Day: February 15, 2021

Sequana Medical announces February-March 2021 Investor Conference Schedule

Written by Customer Service on . Posted in Public Companies.

GHENT, Belgium, Feb. 15, 2021 (GLOBE NEWSWIRE) — Sequana Medical NV (Euronext Brussels: SEQUA, the “Company”), an innovator in the treatment of diuretic-resistant fluid overload in liver disease, malignant ascites and heart failure, today announces that its management team will participate in the following upcoming virtual investor conferences.BTIG Virtual MedTech, Digital Health, Life Science & Diagnostic Tools Conference, 17-19 February 2021Company presentation by Ian Crosbie, CEO, on Thursday 18 February at 16:30 CETH.C. Wainwright Global Life Sciences Conference, 9-10 March 2021Company presentation by Ian Crosbie, CEO, available on demandBioCapital Europe, 11 March 2021Company presentation by Ian Crosbie, CEO, on Thursday 11 March at 15:55 CETTo request a one-on-one meeting with Sequana Medical management at one of these...

Continue reading

Euronext’s statement on governance evolution

Written by Customer Service on . Posted in Public Companies.

EURONEXT’S STATEMENT ON GOVERNANCE EVOLUTIONAmsterdam, Brussels, Dublin, Lisbon, Oslo and Paris  – 15 February 2021 – Euronext today confirms that Piero Novelli has been nominated by the Supervisory Board as an independent member of the Supervisory Board, to become the next Chairman of Euronext N.V. Mr. Novelli will step down from all executive positions before becoming Chairman. The appointment of Mr. Novelli remains subject to the approval of the relevant regulatory authorities and of Euronext shareholders.The convening notice for the General Meeting of Euronext shareholders will be sent in due course.Biography of Mr. Piero NovelliPiero Novelli has been Co-President of the Investment Bank of UBS and a member of UBS Group Executive Board since October 2018. He was appointed Co-Executive Chairman of Global Investment Banking in 2017 and...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.